Don't worry about swine flu vaccines, says WHO

Image
Surinder Sud New Delhi
Last Updated : Jan 20 2013 | 10:39 PM IST

There’s no need to worry on the safety or efficacy of the anti-swine flu vaccines being currently developed in different countries, said the World Health Organization.

Taking notice of the fears being expressed in different quarters on the safety or risks in using the vaccines, the WHO said the regulatory procedures in place for the licencing of pandemic vaccines, including procedures for expediting regulatory approval, are rigorous and do not compromise safety or quality.

Drug companies in several countries are in an advanced stage of developing a H1N1 influenza vaccine to check the swine flu pandemic which has swept across over 160 countries, affecting over 1.5 million (confirmed cases; actual number may be far higher) and killing nearly 1,000 persons. In India, too, over two dozen people have lost their lives due to swine flu in recent weeks, in different cities.

Some Indian drug companies are also engaged in developing a swine flu vaccine based on the seed strain of H1N1 influenza virus provided by the WHO. However, it may take a few months to develop and test the vaccines and get approval for their general use.

In a statement issued from Geneva, the WHO has said: “Influenza vaccines have been used for over 60 years and have an established record of safety in all age groups.”

At the same time, it has also cautioned that some adverse events may arise during a pandemic when the vaccine is administered on a massive scale.

“Some adverse events, which may be too rare to show up even in large clinic trials, may become apparent when very large numbers of people receive a pandemic vaccine,” the WHO has said, while maintaining that such cases will be rare.

It has observed that nearly 50 million people had died in the 1918 world-wide influenza pandemic, largely because vaccines had not been developed by then.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 17 2009 | 1:20 AM IST

Next Story